Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 1426 AL 1440

Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice

Blennow K, Biscetti L, Eusebi P, Parnetti L.

Mov Disord. 2016 Jun;31(6):836-47. doi: 10.1002/mds.26656. Epub 2016 May 4.

Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients

Montarolo F, Perga S, Martire S, Navone DN, Marchet A, Leotta D, Bertolotto A.

Neurotox Res. 2016 Oct;30(3):338-44. doi: 10.1007/s12640-016-9626-4. Epub 2016 May 9.

Methods for the Specific Detection and Quantitation of Amyloid-β Oligomers in Cerebrospinal Fluid

Schuster J, Funke SA.

J Alzheimers Dis. 2016 May 7;53(1):53-67. doi: 10.3233/JAD-151029.

Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jiménez-Urbieta H, Rodriguez-Oroz MC.

Mov Disord. 2016 Jun;31(6):861-81. doi: 10.1002/mds.26662. Epub 2016 May 19.

Protein Amyloidogenesis Investigated by Small Angle Scattering

Ricci C, Spinozzi F, Mariani P, Ortore MG.

Curr Pharm Des. 2016;22(26):3937-49. doi: 10.2174/1381612822666160519113237.

Cognitive interventions in Alzheimer's and Parkinson's diseases: emerging mechanisms and role of imaging

Vemuri P, Fields J, Peter J, Klöppel S.

Curr Opin Neurol. 2016 Aug;29(4):405-11. doi: 10.1097/WCO.0000000000000346.

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, Atik A, Kerr KF, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Montine TJ, Banks WA, Zhang J.

Alzheimers Dement. 2016 Nov;12(11):1125-1131. doi: 10.1016/j.jalz.2016.04.003. Epub 2016 May 24.

TFEB at a glance

Napolitano G, Ballabio A.

J Cell Sci. 2016 Jul 1;129(13):2475-81. doi: 10.1242/jcs.146365. Epub 2016 Jun 1.

Neurologic Diseases in Special Care Patients

Robbins MR.

Dent Clin North Am. 2016 Jul;60(3):707-35. doi: 10.1016/j.cden.2016.03.002.

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)

Singh NA, Mandal AK, Khan ZA.

Nutr J. 2016 Jun 7;15(1):60. doi: 10.1186/s12937-016-0179-4.

[Dementia with motor and language disorders]

Frédéric A, Ghika J.

Rev Med Suisse. 2016 Apr 20;12(515):780-5.

Distribution of PSA-NCAM in normal, Alzheimer's and Parkinson's disease human brain

Murray HC, Low VF, Swanson ME, Dieriks BV, Turner C, Faull RL, Curtis MA.

Neuroscience. 2016 Aug 25;330:359-75. doi: 10.1016/j.neuroscience.2016.06.003. Epub 2016 Jun 7.

[Comparison of naming impairment among patients with Parkinson's disease without dementia, Parkinson's disease dementia and Alzheimer's disease]

Gui XH, Wang LP, Wu CL, Sun XF.

Zhonghua Yi Xue Za Zhi. 2016 Jun 7;96(21):1664-7. doi: 10.3760/cma.j.issn.0376-2491.2016.21.010.

Clinical Epidemiology, Evaluation, and Management of Dementia in Parkinson Disease

Safarpour D, Willis AW.

Am J Alzheimers Dis Other Demen. 2016 Nov;31(7):585-594. doi: 10.1177/1533317516653823. Epub 2016 Jun 13.

Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia

Abdelnour C, van Steenoven I, Londos E, Blanc F, Auestad B, Kramberger MG, Zetterberg H, Mollenhauer B, Boada M, Aarsland D; European DLB Consortium.

Mov Disord. 2016 Aug;31(8):1203-8. doi: 10.1002/mds.26668. Epub 2016 Jun 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias